Dayi Pan

2.6k total citations · 2 hit papers
45 papers, 2.2k citations indexed

About

Dayi Pan is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Dayi Pan has authored 45 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Biomedical Engineering, 20 papers in Biomaterials and 18 papers in Molecular Biology. Recurrent topics in Dayi Pan's work include Nanoplatforms for cancer theranostics (28 papers), Nanoparticle-Based Drug Delivery (19 papers) and Dendrimers and Hyperbranched Polymers (14 papers). Dayi Pan is often cited by papers focused on Nanoplatforms for cancer theranostics (28 papers), Nanoparticle-Based Drug Delivery (19 papers) and Dendrimers and Hyperbranched Polymers (14 papers). Dayi Pan collaborates with scholars based in China, United States and United Kingdom. Dayi Pan's co-authors include Kui Luo, Zhongwei Gu, Qiyong Gong, Chunhua Guo, Hu Zhang, Xiuli Zheng, Chengyuan Zhang, Ning Li, Zhiqian Li and Qiangying Yi and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Biomaterials.

In The Last Decade

Dayi Pan

45 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dendritic Polymer‐Based Nanomedicines Remodel the Tumor Stroma: Improve Drug Penetration and Enhance Antitumor Immune Response

2024 75 citations Dayi Pan, Yunkun Li et al. Advanced Materials profile →
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy

2024 47 citations Zhilin Li, Qianfeng Zhang et al. Acta Pharmaceutica Sinica B profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dayi Pan China	27	1.1k	1.1k	792	449	435	45	2.2k
Yinan Zhong China	25	1.3k 1.2×	1.4k 1.3×	1.0k 1.3×	260 0.6×	374 0.9×	60	2.5k
Ruogu Qi China	29	1.0k 0.9×	1.1k 1.0×	1.1k 1.4×	256 0.6×	637 1.5×	59	2.7k
Kaimin Cai United States	17	1.2k 1.0×	1.0k 1.0×	819 1.0×	162 0.4×	390 0.9×	25	2.1k
Zhaopei Guo China	30	1.2k 1.1×	852 0.8×	1.5k 1.9×	195 0.4×	521 1.2×	80	2.9k
Xianghui Xu China	24	745 0.7×	747 0.7×	821 1.0×	299 0.7×	227 0.5×	62	1.7k
Ying Piao China	26	1.7k 1.5×	1.4k 1.3×	1.3k 1.6×	186 0.4×	504 1.2×	61	3.1k
Shiqun Shao China	20	1.3k 1.1×	1.0k 0.9×	852 1.1×	132 0.3×	321 0.7×	63	2.2k
Takahiro Nomoto Japan	33	1.5k 1.3×	1.6k 1.4×	1.7k 2.2×	244 0.5×	597 1.4×	68	3.5k
Shuang Dou China	20	848 0.8×	1.1k 1.0×	1.3k 1.6×	158 0.4×	293 0.7×	32	2.5k
Wen‐Hsuan Chiang Taiwan	31	1.7k 1.5×	1.3k 1.2×	642 0.8×	133 0.3×	531 1.2×	77	2.6k

Countries citing papers authored by Dayi Pan

Since Specialization

Citations

This map shows the geographic impact of Dayi Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dayi Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dayi Pan more than expected).

Fields of papers citing papers by Dayi Pan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dayi Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dayi Pan. The network helps show where Dayi Pan may publish in the future.

Co-authorship network of co-authors of Dayi Pan

This figure shows the co-authorship network connecting the top 25 collaborators of Dayi Pan. A scholar is included among the top collaborators of Dayi Pan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dayi Pan. Dayi Pan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Xiaoding, Yihan Wang, Maodi Xie, et al.. (2025). Metabolic Targeting of Oxidative Phosphorylation Enhances Chemosensitivity in Triple-Negative Breast Cancer via a Synergistic Nanomedicine. Theranostics. 15(15). 7607–7626. 5 indexed citations

Liu, Guohao, Dayi Pan, Yunkun Li, et al.. (2025). Prodrug-based combinational nanomedicine remodels lipid metabolism for reinforced ferroptosis and immune activation. Acta Pharmaceutica Sinica B. 15(5). 2746–2763. 7 indexed citations

Li, Zhilin, Qianfeng Zhang, Zhiqian Li, et al.. (2024). Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy. Acta Pharmaceutica Sinica B. 14(5). 2194–2209. 47 indexed citations breakdown →

Li, Yunkun, Yuxin Zhang, Dayi Pan, et al.. (2024). Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells. Acta Pharmaceutica Sinica B. 14(8). 3680–3696. 26 indexed citations

Pan, Dayi, et al.. (2024). Dendronized Polymer‐Derived Nanomedicines for Mitochondrial Dynamics Regulation and Immune Modulation. Advanced Materials. 36(25). e2400582–e2400582. 10 indexed citations

Ding, Haitao, Wei Du, Liping Su, et al.. (2023). Revealing the amyloid β-protein with zinc finger protein of micronucleus during Alzheimer's disease progress by a quaternary ammonium terpyridine probe. Biosensors and Bioelectronics. 236. 115446–115446. 2 indexed citations

Li, Zhiqian, Lei Gu, Dayi Pan, et al.. (2023). Stimuli-responsive heparin-drug conjugates co-assembled into stable nanomedicines for cancer therapy. Acta Biomaterialia. 164. 422–434. 12 indexed citations

Xiang, Yufan, Zhiqian Li, Dayi Pan, et al.. (2023). Challenges and Opportunities of Nanomedicine: Novel Comprehensive Approaches for Brain Metastasis. SHILAP Revista de lepidopterología. 5(2). 4 indexed citations

Li, Xiaoling, Zhenyu Duan, Xiaoting Chen, et al.. (2023). Impairing Tumor Metabolic Plasticity via a Stable Metal‐Phenolic‐Based Polymeric Nanomedicine to Suppress Colorectal Cancer. Advanced Materials. 35(23). e2300548–e2300548. 79 indexed citations

10.

Chen, Xiaoting, Zhiqian Li, Lei Gu, et al.. (2023). Modulating tumor-stromal crosstalk via a redox-responsive nanomedicine for combination tumor therapy. Journal of Controlled Release. 356. 525–541. 28 indexed citations

11.

Li, Yinggang, Zhonglan Chen, Lei Gu, et al.. (2022). Anticancer nanomedicines harnessing tumor microenvironmental components. Expert Opinion on Drug Delivery. 19(4). 337–354. 13 indexed citations

12.

Zheng, Xiuli, Dayi Pan, Xiaoting Chen, et al.. (2021). Self‐Stabilized Supramolecular Assemblies Constructed from PEGylated Dendritic Peptide Conjugate for Augmenting Tumor Retention and Therapy. Advanced Science. 8(22). e2102741–e2102741. 42 indexed citations

13.

Guo, Shiwei, Xiaoming Wang, Zhiqian Li, et al.. (2021). A nitroxides-based macromolecular MRI contrast agent with an extraordinary longitudinal relaxivity for tumor imaging via clinical T1WI SE sequence. Journal of Nanobiotechnology. 19(1). 244–244. 16 indexed citations

14.

Wang, Wenjia, Qianfeng Zhang, Zhiqian Li, et al.. (2021). Dendron‐Functionalized Polyglutamate‐Pyropheophorbide‐a Conjugates as Nanomedicines for Breast Cancer Photodynamic Therapy. Macromolecular Rapid Communications. 42(9). e2100013–e2100013. 6 indexed citations

15.

Zhang, Xiaoqin, Yahui Wu, Zhiqian Li, et al.. (2020). Glycodendron/pyropheophorbide-a (Ppa)-functionalized hyaluronic acid as a nanosystem for tumor photodynamic therapy. Carbohydrate Polymers. 247. 116749–116749. 72 indexed citations

16.

Wu, Yahui, Xiaoqin Zhang, Zhiqian Li, et al.. (2020). Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy. Carbohydrate Polymers. 255. 117490–117490. 77 indexed citations

17.

Zhang, Chengyuan, Dayi Pan, Jin Li, et al.. (2017). Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy. Acta Biomaterialia. 55. 153–162. 131 indexed citations

18.

Li, Ning, Na Li, Qiangying Yi, et al.. (2014). Amphiphilic peptide dendritic copolymer-doxorubicin nanoscale conjugate self-assembled to enzyme-responsive anti-cancer agent. Biomaterials. 35(35). 9529–9545. 180 indexed citations

19.

Pan, Dayi, Wenchuan She, Chunhua Guo, et al.. (2014). PEGylated dendritic diaminocyclohexyl-platinum (II) conjugates as pH-responsive drug delivery vehicles with enhanced tumor accumulation and antitumor efficacy. Biomaterials. 35(38). 10080–10092. 81 indexed citations

20.

Yang, Yang, Dayi Pan, Kui Luo, Li Li, & Zhongwei Gu. (2013). Biodegradable and amphiphilic block copolymer–doxorubicin conjugate as polymeric nanoscale drug delivery vehicle for breast cancer therapy. Biomaterials. 34(33). 8430–8443. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact